| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020611 |
| Receipt No. | R000023792 |
| Official scientific title of the study | Significance of sex hormone in the prognosis of patients with idiopathic ventricular fibrillation |
| Date of disclosure of the study information | 2016/01/18 |
| Last modified on | 2019/01/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Significance of sex hormone in the prognosis of patients with idiopathic ventricular fibrillation | |
| Title of the study (Brief title) | Significance of sex hormone in the prognosis of patients with idiopathic ventricular fibrillation | |
| Region |
|
|
| Condition | ||
| Condition | idiopathic ventricular fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the relation between sex hormone and clinical characteristics in patients with idiopathic ventricular fibrillation |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Relationship between sex hormone (testosterone) and clinical characteristics in idiopathic ventricular fibrillation |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with idiopathic ventricular fibrillation (Brugada syndrome, early repolarizaton syndrome, idiopathic ventricular fibrillation of unknown cause) in the National Cerebral and Cardiovascular Center) | |||
| Key exclusion criteria | none | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kusano Kengo |
| Organization | National Cerebral and Cardiovascular Center |
| Division name | Cardiovascular medicine |
| Address | 5-7-1 Fujishiro-dai, Suita, Osaka |
| TEL | 06-6833-5012 |
| kusanokengo@hotmail.com | |
| Public contact | |
| Name of contact person | Kusano Kengo |
| Organization | National Cerebral and Cardiovascular Center |
| Division name | Cardiovascular medicine |
| Address | 5-7-1 Fujishiro-dai, Suita, Osaka |
| TEL | 06-6833-5012 |
| Homepage URL | |
| kusanokengo@hotmail.com | |
| Sponsor | |
| Institute | National Cerebral and Cardiovascular Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Intramural research funds (22-1-2) for cardiovascular disease from National Cerebral and Cardiovascular Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | We could not find no relationship between the serum level of testosterone and occurence of ventricular fibrillation during 2 years follow-up period. |
| Other related information | This study is a single center, prospective and retrospective study.
We are going to take blood samples and evaluate sex hormone (testosterone, etc) in patients with idiopathic ventricular fibrillation, who have been admitted to the National Cerebral and Cardiovascular Center since January, 2016. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023792 |